journal
https://read.qxmd.com/read/38769229/impact-of-etiology-sex-diabetes-mellitus-and-remission-status-on-erythrocytic-profile-in-patients-with-cushing-s-syndrome-a-large-population-database-study
#1
JOURNAL ARTICLE
Laura Dery, Julia Stern, Ilan Shimon, Yaron Rudman, Shiri Kushnir, Tzipora Shochat, Maria Fleseriu, Amit Akirov
PURPOSE: The study aimed to characterize the erythrocytic profile in patients with cushing's syndrome (CS) versus controls from the normal population according to etiology, sex, presence of diabetes mellitus (DM) and hypercortisolemia remission status. METHODS: This retrospective cohort analysis compared erythrocytic parameters between patients with CS of pituitary (CD) and adrenal (aCS) etiology and age, sex, body mass index (BMI) and socioeconomic status-matched controls in a 1:5 ratio...
May 20, 2024: Pituitary
https://read.qxmd.com/read/38767698/headache-in-patients-with-non-functioning-pituitary-adenoma-before-and-after-transsphenoidal-surgery-a-prospective-study
#2
JOURNAL ARTICLE
Victor Hantelius, Oskar Ragnarsson, Gudmundur Johannsson, Daniel S Olsson, Sofie Jakobsson, Erik Thurin, Dan Farahmand, Thomas Skoglund, Tobias Hallen
PURPOSE: To study the long-term effect of transsphenoidal surgery (TSS) on headache in patients with non-functioning pituitary adenoma (NFPA) and identify factors predicting headache relief following TSS. METHODS: We evaluated headache in 101 consecutive patients with NFPA who underwent TSS from September 2015 to December 2021, preoperatively and 12-months post-surgery, by using the Migraine Disability Assessment (MIDAS) questionnaire. Health-related quality of life (QoL) was assessed using the EQ-5D visual analogue scale (EQ-VAS)...
May 20, 2024: Pituitary
https://read.qxmd.com/read/38761322/pituitary-and-covid-19-vaccination-a-systematic-review
#3
REVIEW
Martina Verrienti, Valentino Marino Picciola, Maria Rosaria Ambrosio, Maria Chiara Zatelli
PURPOSE: This systematic review aims to examine the latest research findings and assess the impact of COVID-19 vaccination on the pituitary gland. METHOD: PubMed and Tripdatabase were searched from January 1st, 2020 to February 12th, 2024. Case reports, case series and reviews related to post COVID-19 vaccination pituitary disease were included. Eligible articles were tabulated and analysed in the attempt to provide an overview on the epidemiology, clinical presentation, imaging, treatment, outcomes and pathophysiological background of post COVID-19 vaccination pituitary disease...
May 18, 2024: Pituitary
https://read.qxmd.com/read/38761321/appearance-of-fluid-content-in-rathke-s-cleft-cyst-is-associated-with-clinical-features-and-postoperative-recurrence-rates
#4
JOURNAL ARTICLE
Takamitsu Iwata, Satoru Oshino, Youichi Saitoh, Manabu Kinoshita, Yuji Onoda, Noriyuki Kijima, Kosuke Mukai, Michio Otsuki, Haruhiko Kishima
PURPOSE: The contents of Rathke's cleft cysts (RCCs) vary from clear and slightly viscous to purulent. Surgical treatment of symptomatic RCCs involves removing the cyst contents, whereas additional cyst-wall opening to prevent reaccumulation is at the surgeon's discretion. The macroscopic findings of the cyst content can reflect the nature of RCCs and would aid in surgical method selection. METHODS: We retrospectively reviewed the records of 42 patients with symptomatic RCCs who underwent transsphenoidal surgery at our institute between January 2010 and March 2022...
May 18, 2024: Pituitary
https://read.qxmd.com/read/38748309/repeat-endoscopic-endonasal-transsphenoidal-surgery-for-residual-or-recurrent-cushing-s-disease-safety-feasibility-and-success
#5
JOURNAL ARTICLE
Sahin Hanalioglu, Muhammet Enes Gurses, Neslihan Nisa Gecici, Baylar Baylarov, Ilkay Isikay, Alper Gürlek, Mustafa Berker
PURPOSE: The success and outcomes of repeat endoscopic transsphenoidal surgery (ETS) for residual or recurrent Cushing's disease (CD) are underreported in the literature. This study aims to address this gap by assessing the safety, feasibility, and efficacy of repeat ETS in these patients. METHODS: A retrospective analysis was conducted on 56 patients who underwent a total of 65 repeat ETS performed by a single neurosurgeon between January 2006 and December 2020...
May 15, 2024: Pituitary
https://read.qxmd.com/read/38713317/bone-health-and-skeletal-fragility-in-second-and-third-line-medical-therapies-for-acromegaly-preliminary-results-from-a-pilot-single-center-experience
#6
LETTER
Sabrina Chiloiro, Antonella Giampietro, Amato Infante, Pier Paolo Mattogno, Liverana Lauretti, Alessandro Olivi, Laura De Marinis, Alfredo Pontecorvi, Francesco Doglietto, Antonio Bianchi
INTRODUCTION: Skeletal fragility is a clinically relevant and not-reversible complication of acromegaly, involving around 30-40% of patients since the disease diagnosis. Few studies have investigated the effects on skeletal health of medical therapies for acromegaly. In this retrospective longitudinal monocentre study, we investigated the outcome of skeletal fragility in patients treated with Pasireotide Lar in combination with Pegvisomant (Pasi-Lar + Peg-V), also comparing those observed in patients treated with conventional therapies...
May 7, 2024: Pituitary
https://read.qxmd.com/read/38709467/hypopituitarism-and-bone-disease-pathophysiology-diagnosis-and-treatment-outcomes
#7
REVIEW
Amit Akirov, Yaron Rudman, Maria Fleseriu
Hypopituitarism is a rare but significant endocrine disorder characterized by the inadequate secretion of one or more pituitary hormones. The intricate relationship between hypopituitarism and bone health is a topic of growing interest in the medical community. In this review the authors explore associations between hypopituitarism and bone health, with specific examination of the impact of growth hormone deficiency, central hypogonadism, central hypocortisolism, and central hypothyroidism. Pathogenesis, diagnosis, and treatment options as well as challenges posed by osteopenia, osteoporosis, and fractures in hypopituitarism are discussed...
May 6, 2024: Pituitary
https://read.qxmd.com/read/38700812/the-diagnosis-and-prevalence-of-hypoprolactinemia-in-patients-with-panhypopituitarism-and-the-effects-on-depression-and-sexual-functions
#8
JOURNAL ARTICLE
Ilknur Uzun, Zuleyha Karaca, Aysa Hacioğlu, Kursad Unluhizarci, Fahrettin Kelestimur
PURPOSE: We aimed to investigate the prevalence and the diagnostic criteria of hypoprolactinemia in patients with panhypopituitarism and the effects of hypoprolactinemia on depression and sexual functions. MATERIALS AND METHODS: Forty-eight patients with panhypopituitarism and 20 healthy volunteers were included. Basal hormone levels were measured and a TRH stimulation test was performed. For the evaluation of sexual functions, questionnaries of Female Sexual Functional Index (FSFI) for females and International Erectile Functional Index for males were performed to the subjects...
May 3, 2024: Pituitary
https://read.qxmd.com/read/38656635/quality-of-life-in-prolactinoma-a-systematic-review
#9
JOURNAL ARTICLE
Mendel Castle-Kirszbaum, Nienke Biermasz, Jeremy Kam, Tony Goldschlager
BACKGROUND: Prolactinomas are common tumours that significantly reduce quality-of-life (QOL) due to sellar mass effect, secondary hypogonadism, and the peripheral effects of prolactin. Understanding the factors that influence QOL would provide insights into therapeutic targets to optimise patient outcomes and improve wellbeing in prolactinoma. METHODS: A systematic review was performed in accordance with the PRISMA statement. Studies that reported patient QoL using validated metrics were included...
April 24, 2024: Pituitary
https://read.qxmd.com/read/38521837/changes-in-multi-modality-management-of-acromegaly-in-a-tertiary-centre-over-2-decades
#10
JOURNAL ARTICLE
V Amodru, N Sahakian, C Piazzola, R Appay, T Graillon, T Cuny, I Morange, F Albarel, M Vermalle, J Regis, H Dufour, T Brue, F Castinetti
PURPOSE: Acromegaly is a rare disease associated with chronic multisystem complications. New therapeutic strategies have emerged in the last decades, combining pituitary transsphenoidal surgery (TSS), radiotherapy or radiosurgery (RXT) and medical treatments. METHODS: This retrospective monocentric study focused on presentation, management and outcome of acromegaly patients diagnosed between 2000 and 2020, still followed up in 2020, with a minimum follow-up of 1 year, and comparison of the first vs...
March 23, 2024: Pituitary
https://read.qxmd.com/read/38499816/prolactin-secreting-tumors-dopamine-agonists-and-pregnancy-a-longitudinal-experience-of-a-tertiary-neuroendocrine-center
#11
JOURNAL ARTICLE
Nunzia Prencipe, Chiara Bona, Daniela Cuboni, Alessandro Maria Berton, Fabio Bioletto, Emanuele Varaldo, Luigi Simone Aversa, Michela Sibilla, Valentina Gasco, Ezio Ghigo, Silvia Grottoli
PURPOSE: Prolactin (PRL)-secreting tumours are associated with infertility and can be reverted by dopamine agonist (DA) therapy. The suspension of DA is recommended once pregnancy is established, as all DAs cross the placenta. The aim of the study was to evaluate the rate of maternal-foetal complications in women treated with cabergoline (CAB) or bromocriptine (BRM) for prolactinoma during gestation and the effect of pregnancy on prolactinoma progression. METHODS: This was a retrospective observational study involving 43 women affected by prolactinoma who became pregnant during therapy with CAB or BRM for a total of 58 pregnancies...
March 18, 2024: Pituitary
https://read.qxmd.com/read/38483762/pituitary-tumours-without-distinct-lineage-differentiation-express-stem-cell-marker-sox2
#12
JOURNAL ARTICLE
Nèle F Lenders, Tanya J Thompson, Jeanie Chui, Julia Low, Warrick J Inder, Peter E Earls, Ann I McCormack
CONTEXT: The recent WHO 2022 Classification of pituitary tumours identified a novel group of 'plurihormonal tumours without distinct lineage differentiation (WDLD)'. By definition, these express multiple combinations of lineage commitment transcription factors, in a monomorphous population of cells. OBJECTIVES: To determine the expression of stem cell markers (SOX2, Nestin, CD133) within tumours WDLD, immature PIT-1 lineage and acidophil stem cell tumours, compared with committed cell lineage tumours...
March 14, 2024: Pituitary
https://read.qxmd.com/read/38478212/correction-impulse-control-disorders-in-patients-with-dopamine-agonist-treated-pituitary-adenomas-a-cross-sectional-multicenter-study
#13
Mussa H Almalki, Moayad A Alsuraikh, Eyad Almalki, Faisal Aziz, Raya Almazrouei, Khaled M AlDahmani, Fahad Alshahrani, Meshal Alaqeel, Moeber Mahzari, Aishah Ekhzaimy
No abstract text is available yet for this article.
March 13, 2024: Pituitary
https://read.qxmd.com/read/38270722/successful-treatment-of-medically-and-surgically-refractory-lymphocytic-hypophysitis-with-fractionated-stereotactic-radiotherapy-a-single-center-experience-and-systematic-literature-review
#14
JOURNAL ARTICLE
Mehdi Khaleghi, Guilherme Finger, Kyle C Wu, Vikas Munjal, Luma Ghalib, Peter Kobalka, Dukagjin Blakaj, Khaled Dibs, Ricardo Carrau, Daniel Prevedello
PURPOSE: To explore the potential role of focused radiotherapy in managing the lymphocytic hypophysitis (LH) refractory to medical therapy and surgery. METHOD: A systematic literature review was conducted following PRISMA guidelines to identify the studies on radiation treatment for hypophysitis, along with the experience in our institution. RESULTS: The study included eight patients, three from our institution and five from existing literature...
April 2024: Pituitary
https://read.qxmd.com/read/38183582/current-status-of-artificial-intelligence-technologies-in-pituitary-adenoma-surgery-a-scoping-review
#15
REVIEW
Seyed Farzad Maroufi, Yücel Doğruel, Ahmad Pour-Rashidi, Gurkirat S Kohli, Colson Tomberlin Parker, Tatsuya Uchida, Mohamed Z Asfour, Clara Martin, Mariagrazia Nizzola, Alessandro De Bonis, Mamdouh Tawfik-Helika, Amin Tavallai, Aaron A Cohen-Gadol, Paolo Palmisciano
PURPOSE: Pituitary adenoma surgery is a complex procedure due to critical adjacent neurovascular structures, variations in size and extensions of the lesions, and potential hormonal imbalances. The integration of artificial intelligence (AI) and machine learning (ML) has demonstrated considerable potential in assisting neurosurgeons in decision-making, optimizing surgical outcomes, and providing real-time feedback. This scoping review comprehensively summarizes the current status of AI/ML technologies in pituitary adenoma surgery, highlighting their strengths and limitations...
April 2024: Pituitary
https://read.qxmd.com/read/38381238/glucose-intolerance-in-acromegaly-is-driven-by-low-insulin-secretion-results-from-an-intravenous-glucose-tolerance-test
#16
JOURNAL ARTICLE
Laura Georgiana Zaifu, Dan Alexandru Niculescu, Andreea Elena Kremer, Andra Caragheorgheopol, Mariana Sava, Carmen Nicoleta Iordachescu, Roxana Dusceac, Iulia Florentina Burcea, Catalina Poiana
PURPOSE: Insulin sensitivity (Si ) and its role in glucose intolerance of acromegaly has been extensively evaluated. However, data on insulin secretion is limited. We aimed to assess stimulated insulin secretion using an intravenous glucose tolerance test (IVGTT) in active acromegaly. METHODS: We performed an IVGTT in 25 patients with active acromegaly (13 normal glucose tolerance [NGT], 6 impaired glucose tolerance [IGT] and 6 diabetes mellitus [DM]) and 23 controls (8 lean NGT, 8 obese NGT and 7 obese IGT)...
February 21, 2024: Pituitary
https://read.qxmd.com/read/38345720/elevated-risk-of-recurrence-and-retreatment-for-silent-pituitary-adenomas
#17
JOURNAL ARTICLE
Saksham Gupta, Samantha E Hoffman, Neel H Mehta, Blake Hauser, Marcelle Altshuler, Joshua D Bernstock, Timothy R Smith, Omar Arnaout, Edward R Laws
PURPOSE: Pituitary adenomas are the most common tumor of the pituitary gland and comprise nearly 15% of all intracranial masses. These tumors are stratified into functional or silent categories based on their pattern of hormone expression and secretion. Preliminary evidence supports differential clinical outcomes between some functional pituitary adenoma (FPA) subtypes and silent pituitary adenoma (SPA) subtypes. METHODS: We collected and analyzed the medical records of all patients undergoing resection of SPAs or FPAs from a single high-volume neurosurgeon between 2007 and 2018 at Brigham and Women's Hospital...
February 12, 2024: Pituitary
https://read.qxmd.com/read/38345719/impulse-control-disorders-in-patients-with-dopamine-agonist-treated-pituitary-adenomas-a-cross-sectional-multicenter-study
#18
JOURNAL ARTICLE
Mussa H Almalki, Moayad A Alsuraikh, Eyad Almalki, Faisal Aziz, Raya Almazrouei, Khaled M AlDahmani, Fahad Alshahrani, Meshal Alaqeel, Moeber Mahzari, Aishah Ekhzaimy
BACKGROUND: Impulse control disorders (ICDs) have been described as underrecognized side effects of dopamine agonists (DAs) in neurological disorders but are not sufficiently understood in endocrine conditions. OBJECTIVE: To identify the prevalence of DAs induced ICDs and determine potential risk factors related to these disorders in patients with prolactinoma and non-function pituitary adenomas (NFPAs). METHODS: This is a cross-sectional multicenter study involving 200 patients with prolactinoma and NFPAs, who received follow-ups in tertiary referral centers...
February 12, 2024: Pituitary
https://read.qxmd.com/read/38315244/different-patient-versus-provider-perspectives-on-living-with-cushing-s-disease
#19
JOURNAL ARTICLE
Amanda Halstrom, I-Hsin Lin, Andrew Lin, Marc Cohen, Viviane Tabar, Eliza B Geer
CONTEXT: Patients with Cushing's disease (CD) face challenges living with and receiving appropriate care for this rare, chronic condition. Even with successful treatment, many patients experience ongoing symptoms and impaired quality of life (QoL). Different perspectives and expectations between patients and healthcare providers (HCPs) may also impair well-being. OBJECTIVE: To examine differences in perspectives on living with CD between patients and HCPs, and to compare care goals and unmet needs...
February 5, 2024: Pituitary
https://read.qxmd.com/read/38151529/idiopathic-isolated-adrenocorticotropic-hormone-deficiency-a-systematic-review-of-a-heterogeneous-and-underreported-disease
#20
REVIEW
E Van Mieghem, C De Block, C De Herdt
Isolated adrenocorticotropic hormone deficiency (IAD) is considered to be a rare disease. Due to the nonspecific clinical presentation, precise data on the prevalence and incidence are lacking. In this systematic review, we aimed to analyse the clinical characteristics, association with autoimmune diseases, and management of acquired idiopathic IAD cases. A structured search was conducted after developing a search strategy combining terms for acquired (idiopathic) IAD. Articles describing an adult case with a diagnosis of ACTH deficiency using dynamic testing, no deficiency of other pituitary axes, and MRI of the brain/pituitary protocolled as normal, were included...
February 2024: Pituitary
journal
journal
33080
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.